Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Am J Surg
2 BMC Gastroenterol
2 Dig Dis Sci
1 Gut
2 N Engl J Med
1 Pancreatology
1 PLoS One
1 Scand J Gastroenterol
2 Surgery

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. TAN Q, Wang X, Chen C, Liu X, et al
    Prognostic value of preoperative diabetes mellitus in patients with non-functional pancreatic neuroendocrine neoplasms.
    Am J Surg. 2022 May 25. pii: S0002-9610(22)00378.
    PubMed         Abstract available

    BMC Gastroenterol

  2. KIM JS, Lee SH, Park N, Huh G, et al
    The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis.
    BMC Gastroenterol. 2022;22:271.
    PubMed         Abstract available

  3. GUVENDIR I, Zemheri IE, Ozdil K
    Impact of rapid on-site evaluation on diagnostic accuracy of EUS-guided fine-needle aspiration of solid pancreatic lesions: experience from a single center.
    BMC Gastroenterol. 2022;22:264.
    PubMed         Abstract available

    Dig Dis Sci

  4. WANG ZZ, Li XT, Li QJ, Zhou JX, et al
    Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression.
    Dig Dis Sci. 2022 Jun 1. pii: 10.1007/s10620-022-07529.
    PubMed         Abstract available

  5. SWEI E, Heller JC, Scott F, Attwell A, et al
    Adverse Event Fatalities Related to GI Endoscopy.
    Dig Dis Sci. 2022;67:1753-1760.
    PubMed         Abstract available


  6. DE SANTIS MC, Gozzelino L, Margaria JP, Costamagna A, et al
    Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
    Gut. 2022 May 27. pii: gutjnl-2021-325117. doi: 10.1136/gutjnl-2021-325117.
    PubMed         Abstract available

    N Engl J Med

    T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer.
    N Engl J Med. 2022;386:2143-2144.

  8. LEIDNER R, Sanjuan Silva N, Huang H, Sprott D, et al
    Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
    N Engl J Med. 2022;386:2112-2119.
    PubMed         Abstract available


  9. SATO H, Yoshida R, Yasui K, Umeda Y, et al
    Feasibility of local therapy for recurrent pancreatic cancer.
    Pancreatology. 2022 May 24. pii: S1424-3903(22)00171.
    PubMed         Abstract available

    PLoS One

  10. IWATATE Y, Yokota H, Hoshino I, Ishige F, et al
    Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer.
    PLoS One. 2022;17:e0268630.
    PubMed         Abstract available

    Scand J Gastroenterol

  11. STERNBY H, Andersson B
    Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
    Scand J Gastroenterol. 2022 May 29:1-6. doi: 10.1080/00365521.2022.2078668.
    PubMed         Abstract available


  12. BANNONE E, Marchegiani G, Perri G, Procida G, et al
    Postoperative serum hyperamylasemia (POH) predicts additional morbidity after pancreatoduodenectomy: It is not all about pancreatic fistula.
    Surgery. 2022 May 27. pii: S0039-6060(22)00231.
    PubMed         Abstract available

  13. PERINEL J, Nappo G, Zerbi A, Heidsma CM, et al
    Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.
    Surgery. 2022 May 24. pii: S0039-6060(22)00243.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.